
1001 - 5000 employees
Founded 1991
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Sobi - Swedish Orphan Biovitrum AB (publ) is a global leader in providing innovative treatments for people with rare diseases. Specializing in therapeutic areas such as haematology and immunology, Sobi is committed to improving patient access to medicines for rare and debilitating conditions. With a strong R&D pipeline, the company is actively pursuing new therapies and collaborating globally to transform patient care in areas such as haemophilia and immune thrombocytopenia. Sobi also engages in extensive sustainability and humanitarian aid programs, demonstrating a firm commitment to patient-centric care and societal contributions.
🔥 14 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

1001 - 5000 employees
Founded 1991
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Sobi - Swedish Orphan Biovitrum AB (publ) is a global leader in providing innovative treatments for people with rare diseases. Specializing in therapeutic areas such as haematology and immunology, Sobi is committed to improving patient access to medicines for rare and debilitating conditions. With a strong R&D pipeline, the company is actively pursuing new therapies and collaborating globally to transform patient care in areas such as haemophilia and immune thrombocytopenia. Sobi also engages in extensive sustainability and humanitarian aid programs, demonstrating a firm commitment to patient-centric care and societal contributions.
• Serve as a field-based scientific expert on cutaneous T-cell lymphoma (CTCL) and lacutamab • Build trusted scientific relationships with opinion leaders, healthcare professionals, medical organizations, investigators, and other stakeholders • Exchange balanced medical information on CTCL, lacutamab, clinical data, disease biology, treatment approaches, and the care landscape • Respond to unsolicited scientific inquiries and connect stakeholders with Sobi resources • Identify, document, and share field insights on unmet needs, clinical practice, patient pathways, evidence gaps, stakeholder perspectives, competitive developments, and treatment landscape • Partner with Medical Affairs leadership and cross-functional colleagues to inform medical strategy and engagement plans • Execute territory-level medical plans aligned with the US CTCL and lacutamab medical strategy • Support institution and stakeholder engagement planning • Contribute to lacutamab launch preparedness through education, scientific exchange, stakeholder mapping, and approved medical tactics • Provide internal and external scientific training on CTCL disease biology, preclinical science, clinical data, evidence gaps, and outcomes • Support advisory boards, medical roundtables, webinars, symposia, and educational activities • Represent Sobi Medical Affairs at scientific and medical congresses and communicate key updates internally • Develop field resources and scientific materials specific to CTCL and lacutamab • Support Clinical Development and Clinical Operations with site identification, investigator engagement, site initiation, and patient accrual • Identify evidence gaps and research opportunities • Contribute to evidence generation, real-world evidence, publications, and medical education programs • Support investigator-sponsored research and research collaborations • Collaborate with Medical Affairs, Medical Information, Clinical Development, Market Access, Patient Advocacy, Commercial, Legal, Compliance, and other functions • Lead territory planning, stakeholder prioritization, documentation, follow-through, and multiple projects • Share best practices and support the broader Field Medical organization
• Accredited doctorate degree in a life-science, health-science, or basic-science discipline, such as PharmD, PhD, DNP, DSc, MD, or DO • Candidates with another advanced health degree and extensive relevant industry or clinical experience may be considered • At least 5 years of MSL experience in hematology/oncology, heme-onc, or a closely related therapeutic area • Strong ability to understand, critically evaluate, and clearly communicate complex scientific and clinical information • Clinical hematology-oncology background highly preferred • Knowledge of CTCL and/or PTCL and the multidisciplinary care environment is an advantage • Strong commitment to patient needs and advancing scientific understanding • Frequent domestic travel by ground and/or air is required (60% or more) • Ability to attend local, regional, and national meetings, including occasional evening or weekend programs • Ability to work effectively from a remote office and manage a geographically dispersed territory
• Competitive 401(k) match • Tuition and wellness reimbursements • Comprehensive medical, dental, and vision package • Additional recognition awards • Generous time off policy • Opportunity to attend popular conferences • Work/life balance • Collaborative and team-oriented environment • Short-term and long-term bonuses
Apply Now🔥 21 minutes ago
Field-based Medical Science Liaison advancing GU oncology and NMIBC scientific exchange for EVERSANA’s life-sciences clients. Building expert relationships and supporting Medical Affairs initiatives across the Great Lakes.
🔥 21 minutes ago
Field-based oncology Medical Science Liaison advancing NMIBC therapies for EVERSANA’s life-sciences clients. Building compliant scientific partnerships with healthcare experts across the Mid-Atlantic.
🔥 21 minutes ago
Field-based Medical Science Liaison supporting EVERSANA’s life-sciences commercialization clients in GU oncology. Building scientific relationships and delivering compliant evidence exchange across the Northeast.
🔥 21 minutes ago
Field-based Oncology Medical Science Liaison supporting EVERSANA’s life sciences commercialization services. Building scientific relationships and providing compliant GU Oncology expertise across the Southeast.
🔥 21 minutes ago
Medical Science Liaison advancing GU oncology therapies for EVERSANA’s life-sciences clients. Building compliant scientific relationships and supporting clinical research across the Western U.S.